Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 Pogledi
• 08/04/23
0
0
Ugraditi
administrator
Pretplatnici
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari